Dr. Robert D. Safian, MD

Dr. Safian practices at Corewell Health William Beaumont University Hospital in Royal Oak, Michigan, part of Corewell Health.

Dr. Safian's NPI, 1588646707, was assigned on November 15, 2005. Dr. Safian graduated from University of Florida College of Medicine in 1979. Dr. Safian holds Michigan license 4301058151.

Dr. Safian's primary practice is Corewell Health William Beaumont University Hospital, at 3601 W Thirteen Mile Rd, Royal Oak, MI 48073 in Oakland County. The practice phone is (248) 898-5400.

Dr. Safian's primary practice is Corewell Health William Beaumont University Hospital in Royal Oak, Michigan, part of Corewell Health. Dr. Safian is also affiliated with Corewell Health Beaumont Troy Hospital. The medical group on file is Beaumont Medical Group - Specialty Services.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Safian practices, 2 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Safian's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Safian is licensed in Michigan.

CMS data shows 513 Medicare services from Dr. Safian across 12 procedure codes in 2024, for 334 Medicare patients. Medicare paid $51,417 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 334 Medicare patients who saw Dr. Safian in 2024. The largest group is 65 to 74, with 153 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Safian's median patient age at 63, with 49% women.

In 2024, Dr. Safian wrote 407 Medicare Part D claims for 105 patients. 82% of them were for generic drugs. CMS names the drug for 331 of them, across 13 drugs with 11 or more claims each, at $58,424 in total drug cost. In 2023, CMS named 1,068 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Safian for performance year 2024, reported as part of a group. Dr. Safian accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 37 papers to Dr. Safian, published from 2010 to 2024. 2011 was the busiest year, with 4. The most frequent topics are Cardiac Catheterization, Coronary Angiography and Predictive Value of Tests. Dr. Safian has published most often in Catheter Cardiovasc Interv. Dr. Safian's most frequent co-authors are Amr E. Abbas, MD, George S. Hanzel, MD and Ryan D. Madder, MD.

CMS Open Payments shows 122 general payments to Dr. Safian from 10 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 41% of the total. Medtronic, Inc. paid the most, $14,170.

Dr. Safian graduated from University of Florida College of Medicine in 1979.